>>> US Gapping up

Gapping up
In reaction to strong earnings/guidance
: VCEL +18.6%, STMP +17.7%, HIIQ +12.7%, SODA +12.3%, AEZS +12.1%, CROX +9.2%, CECE +7%, NVRO +6.4%, AKRX +5.6%, WWAV +5.4%, FGEN +4.6%, STXS +4.6%, OPK +4.4%, MHGC +4.3%, DTSI +4.2%, PFNX +4%, HTZ +3.9%, ARNA +3.2%, DPLO +3.1%, HALO +2.9%, XIN +2.9%, GRBK +2.6%, IFF +2.6%, ING +2.6%, OAS +2.5%, KITE +2.1%, MXL +2.1%, GTXI +2%, TREX +2%, TTNP +2%, AGN +2%, TDG +1.9%, TUBE +0.9%, PAH +0.8%

M&A news: ALXA +72.2% (to be acquired by Ferrer Pharma for $0.90 per share), TEX +2.8% (speculation Zoomlion (ZLIOY) could be near completing financing for its previously announced bid to acquire Terex)

Select Chinese ADRs showing strength after late day weakness yesterday: VNET +7.2%, MOMO +5%, AMCN +3.9%, YY +3.5%, QIHU +3.1%

Select metals/mining stocks trading higher: CLF +4%, MTL +3.9%, VALE +3%, FCX +2.4%, EGO +2.1%

Other news: CCXI +111.9% (announces Vifor Pharma has licensed rights to commercialize CCX168), AKRX +7.8% (files form 10-K (previously delayed)), CYTX +3.8% (announces the EC has granted orphan drug status to a broad range of Cytori Cell Therapy formulations), DB +2.7% (in sympathy with CS and ING (both reported earnings, trading higher in EU mkts)), BCS +2.3% (in sympathy with CS and ING (both reported earnings)), AMZN +2.1% ( Acacia Research (ACTG), entered into a settlement and license agreement with Amazon (AMZN)), SNY +1.4% (still checking), HSBC +0.5% (in sympathy with CS and ING (both reported earnings))

Analyst comments: GNC +1% (initiated with a Overweight at Piper Jaffray)